Ampio Pharmaceuticals Accounts Payable

Ampio Pharmaceuticals (AMPE) currently reports a accounts payable of $750K as of December 2023. That compares with $97K in the prior-year period — up 673.2% year over year. Use the charts on this page to explore Ampio Pharmaceuticals's accounts payable history and peer comparisons.

Ampio Pharmaceuticals's accounts payable increased from $97K to $750K — a 673.2% year-over-year increase (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ampio Pharmaceuticals reported $750K in accounts payable as of December 2023. That compares with $97K in the prior-year period — up 673.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $750K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ampio Pharmaceuticals, and consider following AMPE for alerts when major investors trade the stock.

Ampio Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $750K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMPE with unrelated industries.